Abstract
BackgroundAdoptive Cell Transfer (ACT) with tumor infiltrating lymphocytes (TIL) is a novel immunotherapeutic strategy that has shown encouraging results in metastatic melanoma, cervical cancer, and ovarian cancer.1–5 The immunogenic tumor...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have